0XU50KZ
Supplement Axilla, Left to No Qualifier with Nonautologous Tissue Substitute, Open Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | X Anatomical Regions, Upper Extremities |
| Operation | U Supplement |
| Body Part | 5 Axilla, Left |
| Approach | 0 Open |
| Device | K Nonautologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures put in biological or synthetic material to reinforce or augment an upper extremity structure that remains in place, rather than replacing it outright. A typical scenario is applying a mesh or patch graft over an area of weakened soft tissue or fascia in the arm to strengthen it, or augmenting a regional defect with additional material while the native anatomy stays where it is.
This approach is chosen when the existing tissue is intact enough to remain functional but needs added support, commonly after trauma, chronic strain, or a structural weakness identified during another procedure. It differs from a from-scratch repair because material is physically added to bolster the area, and it differs from a full swap because nothing is being removed and replaced.
Anatomy & Axis Detail
Axilla, Left
The left axilla, defined as the soft tissue region at the junction of the arm and chest, becomes a Supplement site when autologous or synthetic material is introduced to reinforce or augment existing tissue, commonly following breast or axillary lymph node surgery that leaves a contour defect or thinned soft tissue coverage. Because this region houses major neurovascular structures serving the arm, supplemental procedures here are generally confined to superficial soft tissue rather than any manipulation of the vessels or nerves themselves, which are coded under their own specific body parts. Accurate documentation of the material placed, whether fat graft, dermal matrix, or mesh, is needed to assign the correct device value, and the native axillary tissue should remain in place, only reinforced rather than removed.
Approach: Open
Open approach means the surgeon cuts through skin, mucous membrane, or other tissue layers to physically expose the target site to view before performing the procedure. It gives direct visualization and hands-on access, distinguishing it from Percutaneous approaches where instruments pass through a small puncture without exposing the site. Open is typical for procedures needing wide access, such as most laparotomies.
Device: Nonautologous Tissue Substitute
Nonautologous Tissue Substitute refers to biologic material sourced from a donor or another species, such as an allograft or xenograft, used to replace a body part. It differs from Autologous Tissue Substitute by tissue origin outside the patient's own body, and from Synthetic Substitute by being biologic rather than manufactured material.
Coding & Documentation
Coders assign a code from this family when the operative note documents that graft, mesh, or synthetic material was placed onto or into an existing upper extremity structure purely to reinforce or augment it, with the native tissue left intact, and the documentation should specify the material type and the exact regional location covered. A common error is coding Supplement when the surgeon actually excised damaged tissue first and put in a substitute, which belongs under Replacement instead. Another recurring issue is failing to capture whether the reinforcing material is autologous, nonautologous, or synthetic, since this qualifier changes the specific code and is easy to overlook if the operative note only says "graft placed" without further detail.